Founded in 2023, CT Biotech is a biotechnology company developing probiotics, postbiotics, bacterial cultures, and application-specific formulations.
We create science-based, scalable, and market-ready solutions across food & supplements, hygiene, cosmetics, textiles, indoor air quality, personal care, pet care, hydroponics, agricultural, and biosecurity applications through a range of B2B and B2B2C business models.
Together with our partners, we manage projects from the earliest concept stage through strain selection, formulation development, pilot production, private-label manufacturing, and market launch.
Our Core Activities
- Product development, including R&D, formulation, and market-readiness support
- Supply of bacterial cultures, probiotics, and postbiotic ingredients
- Development of application-specific strains and bacterial blends
- Formulation, prototype, and stability studies
- Private-label and contract manufacturing
- Pilot production and scale-up support
- Joint R&D projects, patent development, and technical consultancy
- Strategic product scouting and sourcing for international markets
- Supply and distribution of strategically important molecules and functional ingredients
- System design for soilless agriculture applications
- Know-how and consultancy services in biotechnology, metabolism, and preventive health-support concepts
- International business development across Türkiye, Korea, and the United States
CT Biotech collaborates with numerous domestic and international companies through project-based partnerships and commercial collaborations. For inquiries or project-related information, please feel free to contact us.
We would love to hear from you.